Regulation and dysregulation of immunoglobulin E: A molecular and clinical perspective

Clinical and Molecular Allergy

Volumn 8, Issue , 2010, Pages

  Pate, Mariah B ^a   Smith, John K ^a   Chi, David S ^a   Krishnaswamy, Guha ^a,b  

^a East Tennessee State University   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALPHA INTERFERON; BETA INTERFERON; DIETHYLCARBAMAZINE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 8; IVERMECTIN; LYMPHOTOXIN; MEBENDAZOLE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; THYMIC STROMAL LYMPHOPOIETIN; TINIDAZOLE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA;

ATOPY; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BIOLOGICAL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELLULAR IMMUNITY; CLINICAL FEATURE; DIGEORGE SYNDROME; DISEASE ASSOCIATION; GENE REARRANGEMENT; GIARDIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPER IGE SYNDROME; IMMUNE DYSREGULATION; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFECTION CONTROL; INFECTION PREVENTION; IPEX SYNDROME; MOLECULAR DYNAMICS; MYELOMA; NEPHRITIS; NONHUMAN; OMENN SYNDROME; REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT DISEASE; REVIEW; SKIN DISEASE; SOLID TUMOR; STRONGYLOIDIASIS; TH1 CELL; TH17 CELL; TH2 CELL; TOXOCARIASIS; TRICHINOSIS; WISKOTT ALDRICH SYNDROME;

EID: 77649326083     PISSN: None     EISSN: 14767961     Source Type: Journal    
DOI: 10.1186/1476-7961-8-3     Document Type: Review

References (96)

1. Williams AF, Barclay AN. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol 1988, 6:381-405.
2. Krishnaswamy G, Hall K, Youngberg G, Hossler F, Johnson D, Block WA, Huang SK, Kelley J, Chi DS. Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells. J Interferon Cytokine Res 2002, 22:379-388. 10.1089/107999002753675811, 12034046.
3. Chi DS, Fitzgerald SM, Krishnaswamy G. Mast cell histamine and cytokine assays. Methods Mol Biol 2006, 315:203-215.
4. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol 2006, 315:13-34.
5. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol 2004, 31:283-291. 10.1165/rcmb.2004-0089OC, 15191916.
6. Shakoory B, Fitzgerald SM, Lee SA, Chi DS, Krishnaswamy G. The role of human mast cell-derived cytokines in eosinophil biology. J Interferon Cytokine Res 2004, 24:271-281. 10.1089/107999004323065057, 15153310.
7. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003, 3:721-732. 10.1038/nri1181, 12949496.
8. de Vries JE, Punnonen J, Cocks BG, de Waal MR, Aversa G. Regulation of the human IgE response by IL4 and IL13. Res Immunol 1993, 144:597-601. 10.1016/S0923-2494(05)80009-4, 7905652.
9. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994, 264:1152-1156. 10.1126/science.8178175, 8178175.
10. Polmar SH, Waldmann TA, Balestra ST, Jost MC, Terry WD. Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia. J Clin Invest 1972, 51:326-330. 10.1172/JCI106817, 302130, 5009116.
11. Waldmann TA, Polmar SH, Balestra ST, Jost MC, Bruce RM, Terry WD. Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome. J Immunol 1972, 109:304-310.
12. Ammann AJ, Roth J, Hong R. Recurrent sinopulmonary infections, mental retardation, and combined IgA and IgE deficiency. J Pediatr 1970, 77:802-804. 10.1016/S0022-3476(70)80238-4, 4100838.
13. Schoettler JJ, Schleissner LA, Heiner DC. Familial IgE deficiency associated with sinopulmonary disease. Chest 1989, 96:516-521. 10.1378/chest.96.3.516, 2766811.
14. Secord EA, Kleiner GI, Auci DL, Smith-Norowitz T, Chice S, Finkielstein A, Nowakowski M, Fikrig S, Durkin HG. IgE against HIV proteins in clinically healthy children with HIV disease. J Allergy Clin Immunol 1996, 98:979-984. 10.1016/S0091-6749(96)80015-7, 8939162.
15. Pellegrino MG, Bluth MH, Smith-Norowitz T, Fikrig S, Volsky DJ, Moallem H, Auci DL, Nowakowski M, Durkin HG. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro. AIDS Res Hum Retroviruses 2002, 18:363-372. 10.1089/088922202753519142, 11897038.
16. Bereczky S, Montgomery SM, Troye-Blomberg M, Rooth I, Shaw MA, Farnert A. Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria. Int J Parasitol 2004, 34:935-942. 10.1016/j.ijpara.2004.04.007, 15217732.
17. Duarte J, Deshpande P, Guiyedi V, Mecheri S, Fesel C, Cazenave PA, Mishra GC, Kombila M, Pied S. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malar J 2007, 6:1. 10.1186/1475-2875-6-1, 17204149, 1781948.
18. Bluth MH, Robin J, Ruditsky M, Norowitz KB, Chice S, Pytlak E, Nowakowski M, Durkin HG, Smith-Norowitz TA. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease. Scand J Immunol 2007, 65:376-382. 10.1111/j.1365-3083.2007.01904.x, 17386029.
19. Pritchard DI, Walsh EA. The specificity of the human IgE response to Necator americanus. Parasite Immunol 1995, 17:605-607. 10.1111/j.1365-3024.1995.tb01005.x, 8817608.
20. Reali E, Greiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG. IgEs targeted on tumor cells: therapeutic activity and potential in the design of tumor vaccines. Cancer Res 2001, 61:5517-5522.
21. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH. Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008, 153:401-409. 10.1111/j.1365-2249.2008.03726.x, 2527370, 18803764.
22. Smith JK, Krishnaswamy GH, Dykes R, Reynolds S, Berk SL. Clinical manifestations of IgE hypogammaglobulinemia. Ann Allergy Asthma Immunol 1997, 78:313-318.
23. Liblau RS, Bach JF. Selective IgA deficiency and autoimmunity. Int Arch Allergy Immunol 1992, 99:16-27. 10.1159/000236330, 1483063.
24. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998, 12:1255-1265.
25. Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005, 296:1-17. full_text, 16329189.
26. Cunningham-Rundles C, Brandeis WE, Pudifin DJ, Day NK, Good RA. Autoimmunity in selective IgA deficiency: relationship to anti-bovine protein antibodies, circulating immune complexes and clinical disease. Clin Exp Immunol 1981, 45:299-304. 1537366, 7318256.
27. Paliard X, West SG, Lafferty JA, Clements JR, Kappler JW, Marrack P, Kotzin BL. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991, 253:325-329. 10.1126/science.1857971, 1857971.
28. Cooke A, Lydyard PM, Roitt IM. Autoimmunity and idiotypes. Lancet 1984, 2:723-725. 10.1016/S0140-6736(84)92628-X, 6148475.
29. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988, 52:773-782. 10.1016/0092-8674(88)90414-X, 2449974.
30. Kitaura J, Song J, Tsai M, Asai K, Maeda-Yamamoto M, Mocsai A, Kawakami Y, Liu FT, Lowell CA, Barisas BG, Galli SJ, Kawakami T. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 2003, 100:12911-12916. 10.1073/pnas.1735525100, 240718, 14569021.
31. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van SJ, Strom TB, Zheng XX, Noelle RJ. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002. 10.1038/nature05010, 16921386.
32. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, Szeto CC. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford) 2006, 45:951-957. 10.1093/rheumatology/kel029, 16461436.
33. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 2000, 59:263-268. 10.1136/ard.59.4.263, 1753106, 10733472.
34. Levy DA, Chen J. Healthy IgE-deficient person. N Engl J Med 1970, 283:541-542.
35. Kang HS, Blink SE, Chin RK, Lee Y, Kim O, Weinstock J, Waldschmidt T, Conrad D, Chen B, Solway J, Sperling AI, Fu YX. Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation. J Exp Med 2003, 198:1643-1652. 10.1084/jem.20021784, 2194142, 14638845.
36. Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008, 122:1054-1062. 10.1016/j.jaci.2008.10.023, 19084106.
37. Ring J, Landthaler M. Hyper-IgE syndromes. Curr Probl Dermatol 1989, 18:79-88.
38. Heimall J, Freeman A, Holland SM. Pathogenesis of Hyper IgE Syndrome. Clin Rev Allergy Immunol 2009,
39. Tangye SG, Cook MC, Fulcher DA. Insights into the role of STAT3 in human lymphocyte differentiation as revealed by the hyper-IgE syndrome. J Immunol 2009, 182:21-28.
40. Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep 2008, 8:386-391. 10.1007/s11882-008-0075-x, 18682102.
41. Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, Bonfanti R, Sznajer Y, Tommasini A, Lawitschka A, Junker A, Dunstheimer D, Heidemann PH, Cazzola G, Cipolli M, Friedrich W, Janic D, Azzi N, Richmond E, Vignola S, Barabino A, Chiumello G, Azzari C, Roncarolo MG, Bacchetta R. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol 2008, 122:1105-1112. 10.1016/j.jaci.2008.09.027, 18951619.
42. Smith DL, Bahna SL, Gillis TP, Clements BH. Atopy and IgE in patients with leprosy. J Allergy Clin Immunol 1990, 85:795-800. 10.1016/0091-6749(90)90201-E, 2182698.
43. Imai T, Katada H, Mikami R, Nishikawa K, Sawaki M, Ishibashi J, Konoike Y, Sawaki M, Nakano H, Mikasa K. [Serum IgE level in pulmonary tuberculosis. Comparison with other respiratory diseases]. Kekkaku 1984, 59:483-490.
44. Ellertsen LK, Wiker HG, Egeberg NT, Hetland G. Allergic sensitisation in tuberculosis and leprosy patients. Int Arch Allergy Immunol 2005, 138:217-224. 10.1159/000088722, 16210860.
45. Yong AJ, Grange JM, Tee RD, Beck JS, Bothamley GH, Kemeny DM, Kardjito T. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. Tubercle 1989, 70:273-279. 10.1016/0041-3879(89)90021-4, 2516671.
46. Marone G, Florio G, Triggiani M, Petraroli A, de PA. Mechanisms of IgE elevation in HIV-1 infection. Crit Rev Immunol 2000, 20:477-496.
47. Mazza DS, Grieco MH, Reddy MM, Meriney D. Serum IgE in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1995, 74:411-414.
48. Ferrazzi M, De Rinaldis ML, Salotti A, Cirelli A. Serum IgE levels in human immunodeficiency virus (HIV)-1 infected patients: correlation between IgE and CD4+ cells. Riv Eur Sci Med Farmacol 1993, 15:67-70.
49. Zar HJ, Latief Z, Hughes J, Hussey G. Serum immunoglobulin E levels in human immunodeficiency virus-infected children with pneumonia. Pediatr Allergy Immunol 2002, 13:328-333. 10.1034/j.1399-3038.2002.02019.x, 12431191.
50. Rancinan C, Morlat P, Chene G, Guez S, Baquey A, Beylot J, Salamon R. IgE serum level: a prognostic marker for AIDS in HIV-infected adults?. J Allergy Clin Immunol 1998, 102:329-330. 10.1016/S0091-6749(98)70107-1, 9723683.
51. Paganelli R, Scala E, Ansotegui IJ, Mezzaroma I, Pinter E, Ferrara R, D'Offizi GP, Aiuti F. Hyper IgE syndrome induced by HIV infection. Immunodeficiency 1993, 4:149-152.
52. Fincham JE, Markus MB, van der ML, Adams VJ, van Stuijvenberg ME, Dhansay MA. Ascaris, co-infection and allergy: the importance of analysis based on immunological variables rather than egg excretion. Trans R Soc Trop Med Hyg 2007, 101:680-682. 10.1016/j.trstmh.2006.11.006, 17254621.
53. Rosenberg EB, Whalen GE, Bennich H, Johansson SG. Increased circulating IgE in a new parasitic disease--human intestinal capillariasis. N Engl J Med 1970, 283:1148-1149.
54. Kong Y, Ito A, Yang HJ, Chung YB, Kasuya S, Kobayashi M, Liu YH, Cho SY. Immunoglobulin G (IgG) subclass and IgE responses in human paragonimiases caused by three different species. Clin Diagn Lab Immunol 1998, 5:474-478. 95602, 9665951.
55. Espino AM, Osuna A, Gil R, Hillyer GV. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice. Exp Parasitol 2005, 110:374-383. 10.1016/j.exppara.2005.03.029, 15907838.
56. Pfister K, Turner K, Currie A, Hall E, Jarrett EE. IgE production in rat fascioliasis. Parasite Immunol 1983, 5:587-593. 10.1111/j.1365-3024.1983.tb00775.x, 6657297.
57. Jiz M, Friedman JF, Leenstra T, Jarilla B, Pablo A, Langdon G, Pond-Tor S, Wu HW, Manalo D, Olveda R, Acosta L, Kurtis JD. Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. Infect Immun 2009, 77:2051-2058. 10.1128/IAI.00012-09, 2681753, 19273558.
58. Makhlouf LM, Serwah A, bd El-Hamid AD, Hussein EM, Saad RM. INF-gamma, IL-5 and IgE profiles in chronic schistosomiasis mansoni Egyptian patients with or without hepatitis C infection. J Egypt Soc Parasitol 2006, 36:177-196.
59. Loukas A, Prociv P. Immune responses in hookworm infections. Clin Microbiol Rev 2001, 14:689-703. table., 10.1128/CMR.14.4.689-703.2001, 89000, 11585781.
60. Khabiri AR, Bagheri F, Assmar M, Siavashi MR. Analysis of specific IgE and IgG subclass antibodies for diagnosis of Echinococcus granulosus. Parasite Immunol 2006, 28:357-362. 10.1111/j.1365-3024.2006.00837.x, 16879307.
61. Abraham D, Leon O, Schnyder-Candrian S, Wang CC, Galioto AM, Kerepesi LA, Lee JJ, Lustigman S. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infect Immun 2004, 72:810-817. 10.1128/IAI.72.2.810-817.2004, 321619, 14742524.
62. Duarte J, Deshpande P, Guiyedi V, Mecheri S, Fesel C, Cazenave PA, Mishra GC, Kombila M, Pied S. Total and functional parasite specific IgE responses in Plasmodium falciparum-infected patients exhibiting different clinical status. Malar J 2007, 6:1. 10.1186/1475-2875-6-1, 1781948, 17204149.
63. Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 2006, 4:8. 10.1186/1476-7961-4-8, 1538622, 16734908.
64. Olsen A, van LL, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P. Strongyloidiasis - the most neglected of the neglected tropical diseases?. Trans R Soc Trop Med Hyg 2009,
65. Khasawneh F, Sreedhar R, Chundi V. Strongyloides hyperinfection: an unusual cause of respiratory failure. Ann Intern Med 2009, 150:570-571.
66. Gawor J, Borecka A, Dobosz S, Marczynska M, Zarnowska-Prymek H, Trzebicka A, Juszko J. [Toxocariasis in children--difficult clinical problem]. Przegl Epidemiol 2008, 62:407-413.
67. Obwaller A, Jensen-Jarolim E, Auer H, Huber A, Kraft D, Aspock H. Toxocara infestations in humans: symptomatic course of toxocarosis correlates significantly with levels of IgE/anti-IgE immune complexes. Parasite Immunol 1998, 20:311-317. 10.1046/j.1365-3024.1998.00146.x, 9717192.
68. Gottstein B, Pozio E, Nockler K. Epidemiology, diagnosis, treatment, and control of trichinellosis. Clin Microbiol Rev 2009, 22:127-45. Table., 10.1128/CMR.00026-08, 2620635, 19136437.
69. Geller M, Geller M, Flaherty DK, Black P, Madruga M. Serum IgE levels in giardiasis. Clin Allergy 1978, 8:69-71. 10.1111/j.1365-2222.1978.tb00450.x, 627045.
70. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodriguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 2008, 63:1255-1266. 10.1111/j.1398-9995.2008.01768.x, 18671772.
71. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996, 9:532-562. 172909, 8894351.
72. Hsu SM. IgE in Reed-Sternberg cells. Blood 1992, 80:286-287.
73. Matta GM, Battaglio S, Dibello C, Napoli P, Baldi C, Ciccone G, Coscia M, Boccadoro M, Massaia M. Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma. Clin Cancer Res 2007, 13:5348-5354. 10.1158/1078-0432.CCR-06-2819, 17875762.
74. Lloyd L, Klingberg SL, Kende M, Howell JF, Clague AE. A case of IgE multiple myeloma. Pathology 2003, 35:87-89. 10.1080/0031302021000062424, 12701695.
75. Kusakawa S, Heiner DC. Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome. Pediatr Res 1976, 10:108-111. 10.1203/00006450-197602000-00007, 1705.
76. Krous HF, Clausen CR, Ray CG. Elevated immunoglobulin E in infantile polyarteritis nodosa. J Pediatr 1974, 84:841-845. 10.1016/S0022-3476(74)80760-2, 4151180.
77. Huang JT. Serum IgE concentrations in neurological diseases. Ann Allergy 1975, 34:1-6.
78. Roca GA, Palomeque RA, Pastor D, X, Molinero EC, Jimenez GR. [Guillain-Barre syndrome: a study of 13 children]. An Esp Pediatr 1993, 39:513-516.
79. Horiuchi I, Kawano Y, Yamasaki K, Matsuo H, Minohara M, Nakamura T, Hashiguchi H, Ohyagi Y, Yamada T, Kira J. Heightened IgE response to mite antigens in inflammatory neuropathies. J Neurol Sci 1999, 166:77-80. 10.1016/S0022-510X(99)00098-2, 10475098.
80. Polacek V, Jira M, Fara M, Strejcek J, Konigova R. Immunoglobulin E (IgE) in patients with severe burns. Burns Incl Therm Inj 1987, 13:458-461.
81. Elagina LV, Lagvilava MG, Gordeev VF. [Value of determining serum immunoglobulin E in burn patients]. Klin Med (Mosk) 1986, 64:124-126.
82. Azuma N, Katada Y, Harada Y, Arimoto H, Kimura Y, Terada H, Tsujino K, Kida H, Yamamoto S, Kudo E, Umeshita M, Mima T, Saeki Y. [Case of primary Sjogren's syndrome with hypereosinophilia and elevation of serum IgE: measurements of serum IL-4, IL-5 and the IgG subclass]. Arerugi 2005, 54:646-651.
83. Ferreira RA, Ferriani VP, Sopelete MC, Silva DA, Mineo JR, Kiss MH, Silva CH. Immunoglobulin E-rheumatoid factor in juvenile rheumatoid arthritis. Rev Hosp Clin Fac Med Sao Paulo 2002, 57:209-216.
84. Heyd J, Donnenberg AD, Burns WH, Saral R, Santos GW. Immunoglobulin E levels following allogeneic, autologous, and syngeneic bone marrow transplantation: an indirect association between hyperproduction and acute graft-v-host disease in allogeneic BMT. Blood 1988, 72:442-446.
85. Romano C, Sellitto A, De FU, Rossiello R, Rossiello L, Giunta R, Lucivero G. A scleroderma-like cutaneous syndrome associated with a marked Th2-type immune response occurring after a prosthetic joint implant. J Clin Rheumatol 2009, 15:133-137. 10.1097/RHU.0b013e31819e6798, 19300283.
86. Tokura Y, Sugita K, Kabashima K, Ito T, Yagi H. Alopecia universalis associated with impaired interleukin-4 production and low serum IgE level. J Am Acad Dermatol 2007, 57:S22-S25. 10.1016/j.jaad.2006.12.032, 17637364.
87. Kasumagic-Halilovic E, Prohic A. Serum levels of total immunoglobulin e in patients with alopecia areata: relationship with clinical type of the disease. Acta Dermatovenerol Croat 2006, 14:149-152.
88. Mandalenaki-Lambrou C, Thomaidis T, Benetos S, Ladis B, Matsaniotis N. Immunoglobulin E in erythema nodosum. Arch Dis Child 1976, 51:391-393. 10.1136/adc.51.5.391, 1545978, 938083.
89. Bowszyc-Dmochowska M, Dmochowski M. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts. J Med 2002, 33:189-198.
90. Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 2008, 144:41-48. 10.1001/archdermatol.2007.9, 18209167.
91. Gonzalez-Quintela A, Vidal C, Gude F. Alcohol-induced alterations in serum immunoglobulin e (IgE) levels in human subjects. Front Biosci 2002, 7:e234-e244. 10.2741/quintela, 11991851.
92. bdel-Hafez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic Nephrotic Syndrome and Atopy: Is There a Common Link?. Am J Kidney Dis 2009,
93. Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol 2004, 19:627-632. 10.1007/s00467-004-1438-8, 15064938.
94. Latzin P, Hartl D, Regamey N, Frey U, Schoeni MH, Casaulta C. Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2008, 31:36-42. 10.1183/09031936.00078107, 17898016.
95. Cozen W, az-Sanchez D, James GW, Zadnick J, Cockburn MG, Gill PS, Masood R, Hamilton AS, Jyrala M, Mack TM. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 2004, 24:617-622. 10.1007/s10875-004-6247-0, 15622446.
96. Moissidis I, Chaidaroon D, Vichyanond P, Bahna SL. Milk-induced pulmonary disease in infants (Heiner syndrome). Pediatr Allergy Immunol 2005, 16:545-552. 10.1111/j.1399-3038.2005.00291.x, 16176405.